Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance

  1. Ponz-Sarvisé, M.
  2. Nguewa, P.A.
  3. Pajares, M.J.
  4. Agorreta, J.
  5. Lozano, M.D.
  6. Redrado, M.
  7. Pio, R.
  8. Behrens, C.
  9. Wistuba, I.I.
  10. García-Franco, C.E.
  11. García-Foncillas, J.
  12. Montuenga, L.M.
  13. Calvo, A.
  14. Gil-Bazo, I.
Aldizkaria:
Clinical Cancer Research

ISSN: 1078-0432,  1557-3265

Argitalpen urtea: 2011

Alea: 17

Zenbakia: 12

Orrialdeak: 4155-4166

Mota: Artikulua

DOI: 10.1158/1078-0432.CCR-10-3381 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus